Key Management for Greystone Pharmaceuticals, Inc.

Bringing together decades of proven success, Greystone Pharmaceuticals, Inc.’s management team looks forward to an extraordinary future.

Gregory P. Pilant, Chairman, CEO and President

Mr. Pilant founded Greystone Pharmaceuticals, Inc. in 1996 and is the Chief Executive Officer and Board Chairman for the company and all of its subsidiaries. In 1991, Mr. Pilant founded and served as President of Prestige International, Inc., an international pharmaceutical marketing company. In 1993, he became CEO of Stanley Pharmaceuticals, Inc., a pharmaceutical developer and manufacturer. Mr. Pilant also served as CEO of National Labs, Inc., a wholly owned orthopedics subsidiary of Stanley Pharmaceuticals.

Kevin R. Douglas, Chief Financial Officer & Chief Operating Officer

Mr. Douglas is the Chief Financial Officer of Greystone Pharmaceuticals, Inc. and its subsidiaries. Most recently, he served as Senior Vice President, Finance, of FlexiInternational Software and was responsible for all aspects of the company’s SEC reporting, financial recording and reporting, and international finance operations. Mr. Douglas has held executive roles in the high-tech medical device, telecommunications and software industries. He earned his CPA designation with Ernst and Young and has owned successful CPA practices in Michigan, Colorado and Florida. Mr. Douglas is a graduate of the University of Michigan.

Dr. Kel Cohen, Chief Medical Officer, Emeritus

Dr. Kel Cohen has devoted his 30+ years in his clinical and surgical career to research on how wounds heal. As the founder and first Chairman of Plastic Surgery at Virginia Commonwealth University in Richmond, he directed the first clinical wound healing center in the USA. He has authored more than 100 scientific articles, texts, papers and journals about wound healing. Dr. Cohen was a founder of the Wound Healing Society and Wound Healing Foundation and has spoken around the world on his research and the clinical management of wounds. He is the recipient of numerous awards including the lifetime achievement awards from both the Wound Healing Society and the Society for the Advancement of Wound Care (SAWC) for his research and clinical work in the wound healing field.

Dan Winnett, Esq., Vice President of Manufacturing and Quality

Dan Winnett graduated cum laude from Southern Illinois University School of Law. He has been involved in the development and management of life science medical ventures. Mr. Winnett has also served as the CEO of Hyperion Medical, a medical device manufacturing company specializing in wound care products.

Mark Wardell, PhD, Vice President of Research and Development

Dr. Mark Wardell has taught at Cambridge University, Hematology Department, U.K. He solved the detailed three dimension structure of protein targets at the atomic level with a view to rational drug design. While at Washington University School of Medicine, he also aided investigations into the fine physiological balance between proteases and protease inhibitors.